Thermo Fisher Scientific delivered its October 21 earnings this morning with the stock already up 3.7% on the week, the Street freshly repriced, and short interest too small to matter. The analyst setup into the print was one of the more decisive re-ratings the stock has seen in a single month. Morgan Stanley lifted its target from $650 to $730 on October 13, keeping an Overweight…
TMO short interest surges 29% in one week to 1.59% of float, driven by activist shorting ahead of UBS upgrade and elevated analyst price targets.
Key data as of 5 Nov 2026
Three distinct signals have converged on TMO this week. An analyst upgrade, a short interest jump, and elevated put-buying are all pointing in different directions at once. UBS analyst Doug Schenkel upgraded TMO to Buy…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TMO — free to start on ORTEX.
Sign up for free →Open TMO on ORTEX